Oral cavity cancer in two young patients with ulcerative colitis, a case report

Abstract

AbstractPatients with Inflammatory Bowel Disease (IBD) are at increased risk of developing malignancies. IBD patients with oral cavity cancer may have reduced survival compared with the general population. This article describes two IBD patients, non-smokers, on long-term use of mesalazine with the development of oral cavity cancer. In IBD the clinician should be aware of possible head and neck malignancies and in case of doubt a biopsy should be performed, even in the absence of standard risk factors.

Keywords

• Inflammatory bowel diseases
• ulcerative colitis
• immunosuppressants
• oral cavity
• head and neck cancer